Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines (Q28259553)

1

0 references

Marcia F E Godinho

2

0 references

Julia D Wulfkuhle

3

0 references

Emanuel F Petricoin

4

0 references

Lambert C J Dorssers

International Journal of Cancer

5

0 references

language of work or name

English

0 references

publication date

1 November 2012

0 references

published in

0 references

volume

131

0 references

issue

9

0 references

page(s)

1998-2007

0 references

cites work

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

1 reference

Use of tamoxifen for breast cancer: twenty-eight years later

21 January 2018

1 reference

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

21 January 2018

1 reference

Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance

21 January 2018

1 reference

Pathways to tamoxifen resistance

21 January 2018

1 reference

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer

21 January 2018

1 reference

Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations

21 January 2018

1 reference

Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site

21 January 2018

1 reference

Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells

21 January 2018

1 reference

Functional identification of genes causing estrogen independence of human breast cancer cells

21 January 2018

1 reference

The prognostic value of BCAR1 in patients with primary breast cancer.

21 January 2018

1 reference

Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer

21 January 2018

1 reference

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.

21 January 2018

1 reference

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer

21 January 2018

1 reference

Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response

21 January 2018

1 reference

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

21 January 2018

1 reference

Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy

21 January 2018

1 reference

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

21 January 2018

1 reference

Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway

21 January 2018

1 reference

BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells

21 January 2018

1 reference

Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells

21 January 2018

1 reference

The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells

21 January 2018

1 reference

Estrogen receptor mutations and changes in downstream gene expression and signaling

21 January 2018

1 reference

Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells

21 January 2018

1 reference

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

AKT activation predicts outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

The STATs of cancer--new molecular targets come of age

21 January 2018

1 reference

BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas.

21 January 2018

1 reference

p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.

21 January 2018

1 reference

CAS proteins in normal and pathological cell growth control

21 January 2018

1 reference

Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling

21 January 2018

1 reference

AND-34/BCAR3 regulates adhesion-dependent p130Cas serine phosphorylation and breast cancer cell growth pattern

21 January 2018

1 reference

NSP1 defines a novel family of adaptor proteins linking integrin and tyrosine kinase receptors to the c-Jun N-terminal kinase/stress-activated protein kinase signaling pathway

21 January 2018

1 reference

Splice variants and expression patterns of SHEP1, BCAR3 and NSP1, a gene family involved in integrin and receptor tyrosine kinase signaling

21 January 2018

1 reference

Novel function of Chat in controlling cell adhesion via Cas-Crk-C3G-pathway-mediated Rap1 activation.

21 January 2018

1 reference

AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology

21 January 2018

1 reference

p130Cas: a versatile scaffold in signaling networks

21 January 2018

1 reference

BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas.

21 January 2018

1 reference

Tumor control versus adverse events with targeted anticancer therapies

21 January 2018

1 reference

Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours

21 January 2018

1 reference

Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer

21 January 2018

1 reference

Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study.

21 January 2018

1 reference

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

21 January 2018

1 reference

Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.

21 January 2018

1 reference